Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) EV to EBITDA (2010 - 2026)

Updated

Immucell's EV to EBITDA was 11.61 in Q3 2026, up 14.0% from 10.19 a year earlier but down 10.8% from the prior quarter.

Analysis

Immucell (ICCC) EV to EBITDA (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Immucell's EV to EBITDA was 8.82 through Sep 30, 2026, up 19.1% year-over-year; for FY2025, it came in at 11.50, down 68.8% from FY2024.

  • In earlier years, EV to EBITDA was 36.90 in FY2024, 185.89 in FY2022 (+889.0%) and 18.80 in FY2021 (-41.5%).
  • Quarterly EV to EBITDA has moved between 9.72 (Q1 2026) and 2031.46 (Q1 2024) over five years.
  • Compared with a year earlier, EV to EBITDA was higher in two of the last six quarters, with an average decline of 44.4%.
  • The best year-over-year quarter for EV to EBITDA over five years was Q4 2022 (growth of 886.2%); the worst was Q1 2025 (a decline of 99.3%).
  • Per Business Quant data, ICCC's EV to EBITDA in the three quarters before Q3 2026 was 13.01 (Q2 2026), 9.72 (Q1 2026) and 11.50 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 11.61
Jun 30, 2026 13.01
Mar 31, 2026 9.72
Dec 31, 2025 11.50
Sep 30, 2025 10.19
Jun 30, 2025 12.57
Mar 31, 2025 14.90
Dec 31, 2024 36.90
Sep 30, 2024 53.35
Mar 31, 2024 2,031.46
Dec 31, 2022 185.89
Sep 30, 2022 24.59
Jun 30, 2022 19.61
Mar 31, 2022 17.02
Dec 31, 2021 18.85
Sep 30, 2021 31.43
Jun 30, 2021 44.12
Mar 31, 2021 136.01
Dec 31, 2020 36.20
Sep 30, 2020 25.44
API Access

Immucell EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ICCC&period=max&api_key=YOUR_API_KEY